Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical dexamethasone hyaluronic acid gel during parotidectomy or neck dissection
ACTRN12618000077268Phase 2Recruiting
- Sponsor
- IVIM Technology
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of dexamethasone in parotid gland cancer and Cervicofacial Cancer (2 arms), sponsored by IVIM Technology. Primary endpoint: Rate of infection. Started Jan 2018; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
parotid gland cancerCervicofacial Cancer
Beyond the preview
Go deeper on ACTRN12618000077268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000077268.